Review



pbluescript  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Addgene inc pbluescript
    Pbluescript, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pbs+mcd4/pBS+mCD4+(Plasmid+%2314613)/pm38876098-660-12-13
    Average 90 stars, based on 6 article reviews
    pbluescript - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Construct:

    Article Title: Epitope Mapping of Ibalizumab, a Humanized Anti-CD4 Monoclonal Antibody with Anti-HIV-1 Activity in Infected Patients
    Article Snippet: .. Mouse CD4 (mCD4)/pVax was constructed by PCR amplification of pBS mCD4 (Addgene, Cambridge, MA) using primers 5 -CCC CCGAATTCCACCATGTGCCGAGCCATCTCTCTT-3 and 5 -CCCCCCTC GAGTCAGATGAGATTATGGCTCTT-3 , which contain the EcoRI and XhoI restriction sites. .. The amplification product was subsequently cloned into the pVAX1 vector (Invitrogen).

    Article Title: The herpesviral antagonist m152 reveals differential activation of STING ‐dependent IRF and NF ‐κB signaling and STING 's dual role during MCMV infection
    Article Snippet: .. Expression constructs for m152‐V5/His, M35‐V5/His, LacZ‐V5/His, and M27‐V5/His (all in pcDNA3.1‐V5/His, Invitrogen) have been described previously (Munks et al , ). pBS‐mCD4 was purchased from Addgene (#14613) and subcloned into pcDNA3.1‐V5/His via the HindIII / BstXI sites to generate pcDNA3.1 mCD4‐V5/His. pcDNA4 ORF36‐myc/His was previously described (Bussey et al , ) and codes for ORF36 of Kaposi's sarcoma‐associated herpesvirus (KSHV). pPolI A/California/04/2009 NS was kindly provided by Toru Takimoto (University of Rochester Medical Center, USA) and subcloned into pcDNA3.1(‐) via the NotI / EcoRI sites to generate pcDNA3.1(‐) Cal NS1. pEFBOS mCherry‐mSTING (designated Cherry‐STING) expressing monomeric Cherry fused to the N terminus of murine STING and pIRESneo3 cGAS‐GFP (GFP fused to the C terminus of human cGAS) were kindly provided by Andrea Ablasser (Global Health Institute, Ecole Polytechnique Fédérale de Lausanne, Switzerland). pcDNA3 hSTING coding for untagged human STING was described previously (Christensen et al , ). pRL‐TK, which expresses Renilla luciferase under control of the thymidine kinase promoter, and pIRES2‐GFP were purchased from Promega and Clontech, respectively. pNF‐κB Luc, containing five NF‐κB responsive elements (TGGGGACTTTCCGC) upstream of the firefly luciferase gene, is commercially available from Agilent Technologies. pGL3basic IFNβ‐Luc (IFNβ‐Luc) and pGL3basic ISG56‐Luc (ISG56‐Luc) were described previously (Chan et al , ). ..

    Article Title: Epitope Mapping of Ibalizumab, a Humanized Anti-CD4 Monoclonal Antibody with Anti-HIV-1 Activity in Infected Patients
    Article Snippet: .. Mouse CD4 (mCD4)/pVax was constructed by PCR amplification of pBS mCD4 (Addgene, Cambridge, MA) using primers 5′-CCCCCGAATTCCACCATGTGCCGAGCCATCTCTCTT-3′ and 5′-CCCCCCTCGAGTCAGATGAGATTATGGCTCTT-3′, which contain the EcoRI and XhoI restriction sites. .. The amplification product was subsequently cloned into the pVAX1 vector (Invitrogen).

    Polymerase Chain Reaction:

    Article Title: Epitope Mapping of Ibalizumab, a Humanized Anti-CD4 Monoclonal Antibody with Anti-HIV-1 Activity in Infected Patients
    Article Snippet: .. Mouse CD4 (mCD4)/pVax was constructed by PCR amplification of pBS mCD4 (Addgene, Cambridge, MA) using primers 5 -CCC CCGAATTCCACCATGTGCCGAGCCATCTCTCTT-3 and 5 -CCCCCCTC GAGTCAGATGAGATTATGGCTCTT-3 , which contain the EcoRI and XhoI restriction sites. .. The amplification product was subsequently cloned into the pVAX1 vector (Invitrogen).

    Article Title: Epitope Mapping of Ibalizumab, a Humanized Anti-CD4 Monoclonal Antibody with Anti-HIV-1 Activity in Infected Patients
    Article Snippet: .. Mouse CD4 (mCD4)/pVax was constructed by PCR amplification of pBS mCD4 (Addgene, Cambridge, MA) using primers 5′-CCCCCGAATTCCACCATGTGCCGAGCCATCTCTCTT-3′ and 5′-CCCCCCTCGAGTCAGATGAGATTATGGCTCTT-3′, which contain the EcoRI and XhoI restriction sites. .. The amplification product was subsequently cloned into the pVAX1 vector (Invitrogen).

    Amplification:

    Article Title: Epitope Mapping of Ibalizumab, a Humanized Anti-CD4 Monoclonal Antibody with Anti-HIV-1 Activity in Infected Patients
    Article Snippet: .. Mouse CD4 (mCD4)/pVax was constructed by PCR amplification of pBS mCD4 (Addgene, Cambridge, MA) using primers 5 -CCC CCGAATTCCACCATGTGCCGAGCCATCTCTCTT-3 and 5 -CCCCCCTC GAGTCAGATGAGATTATGGCTCTT-3 , which contain the EcoRI and XhoI restriction sites. .. The amplification product was subsequently cloned into the pVAX1 vector (Invitrogen).

    Article Title: Epitope Mapping of Ibalizumab, a Humanized Anti-CD4 Monoclonal Antibody with Anti-HIV-1 Activity in Infected Patients
    Article Snippet: .. Mouse CD4 (mCD4)/pVax was constructed by PCR amplification of pBS mCD4 (Addgene, Cambridge, MA) using primers 5′-CCCCCGAATTCCACCATGTGCCGAGCCATCTCTCTT-3′ and 5′-CCCCCCTCGAGTCAGATGAGATTATGGCTCTT-3′, which contain the EcoRI and XhoI restriction sites. .. The amplification product was subsequently cloned into the pVAX1 vector (Invitrogen).

    Countercurrent Chromatography:

    Article Title: Epitope Mapping of Ibalizumab, a Humanized Anti-CD4 Monoclonal Antibody with Anti-HIV-1 Activity in Infected Patients
    Article Snippet: .. Mouse CD4 (mCD4)/pVax was constructed by PCR amplification of pBS mCD4 (Addgene, Cambridge, MA) using primers 5 -CCC CCGAATTCCACCATGTGCCGAGCCATCTCTCTT-3 and 5 -CCCCCCTC GAGTCAGATGAGATTATGGCTCTT-3 , which contain the EcoRI and XhoI restriction sites. .. The amplification product was subsequently cloned into the pVAX1 vector (Invitrogen).

    Expressing:

    Article Title: The herpesviral antagonist m152 reveals differential activation of STING ‐dependent IRF and NF ‐κB signaling and STING 's dual role during MCMV infection
    Article Snippet: .. Expression constructs for m152‐V5/His, M35‐V5/His, LacZ‐V5/His, and M27‐V5/His (all in pcDNA3.1‐V5/His, Invitrogen) have been described previously (Munks et al , ). pBS‐mCD4 was purchased from Addgene (#14613) and subcloned into pcDNA3.1‐V5/His via the HindIII / BstXI sites to generate pcDNA3.1 mCD4‐V5/His. pcDNA4 ORF36‐myc/His was previously described (Bussey et al , ) and codes for ORF36 of Kaposi's sarcoma‐associated herpesvirus (KSHV). pPolI A/California/04/2009 NS was kindly provided by Toru Takimoto (University of Rochester Medical Center, USA) and subcloned into pcDNA3.1(‐) via the NotI / EcoRI sites to generate pcDNA3.1(‐) Cal NS1. pEFBOS mCherry‐mSTING (designated Cherry‐STING) expressing monomeric Cherry fused to the N terminus of murine STING and pIRESneo3 cGAS‐GFP (GFP fused to the C terminus of human cGAS) were kindly provided by Andrea Ablasser (Global Health Institute, Ecole Polytechnique Fédérale de Lausanne, Switzerland). pcDNA3 hSTING coding for untagged human STING was described previously (Christensen et al , ). pRL‐TK, which expresses Renilla luciferase under control of the thymidine kinase promoter, and pIRES2‐GFP were purchased from Promega and Clontech, respectively. pNF‐κB Luc, containing five NF‐κB responsive elements (TGGGGACTTTCCGC) upstream of the firefly luciferase gene, is commercially available from Agilent Technologies. pGL3basic IFNβ‐Luc (IFNβ‐Luc) and pGL3basic ISG56‐Luc (ISG56‐Luc) were described previously (Chan et al , ). ..

    Luciferase:

    Article Title: The herpesviral antagonist m152 reveals differential activation of STING ‐dependent IRF and NF ‐κB signaling and STING 's dual role during MCMV infection
    Article Snippet: .. Expression constructs for m152‐V5/His, M35‐V5/His, LacZ‐V5/His, and M27‐V5/His (all in pcDNA3.1‐V5/His, Invitrogen) have been described previously (Munks et al , ). pBS‐mCD4 was purchased from Addgene (#14613) and subcloned into pcDNA3.1‐V5/His via the HindIII / BstXI sites to generate pcDNA3.1 mCD4‐V5/His. pcDNA4 ORF36‐myc/His was previously described (Bussey et al , ) and codes for ORF36 of Kaposi's sarcoma‐associated herpesvirus (KSHV). pPolI A/California/04/2009 NS was kindly provided by Toru Takimoto (University of Rochester Medical Center, USA) and subcloned into pcDNA3.1(‐) via the NotI / EcoRI sites to generate pcDNA3.1(‐) Cal NS1. pEFBOS mCherry‐mSTING (designated Cherry‐STING) expressing monomeric Cherry fused to the N terminus of murine STING and pIRESneo3 cGAS‐GFP (GFP fused to the C terminus of human cGAS) were kindly provided by Andrea Ablasser (Global Health Institute, Ecole Polytechnique Fédérale de Lausanne, Switzerland). pcDNA3 hSTING coding for untagged human STING was described previously (Christensen et al , ). pRL‐TK, which expresses Renilla luciferase under control of the thymidine kinase promoter, and pIRES2‐GFP were purchased from Promega and Clontech, respectively. pNF‐κB Luc, containing five NF‐κB responsive elements (TGGGGACTTTCCGC) upstream of the firefly luciferase gene, is commercially available from Agilent Technologies. pGL3basic IFNβ‐Luc (IFNβ‐Luc) and pGL3basic ISG56‐Luc (ISG56‐Luc) were described previously (Chan et al , ). ..

    Control:

    Article Title: The herpesviral antagonist m152 reveals differential activation of STING ‐dependent IRF and NF ‐κB signaling and STING 's dual role during MCMV infection
    Article Snippet: .. Expression constructs for m152‐V5/His, M35‐V5/His, LacZ‐V5/His, and M27‐V5/His (all in pcDNA3.1‐V5/His, Invitrogen) have been described previously (Munks et al , ). pBS‐mCD4 was purchased from Addgene (#14613) and subcloned into pcDNA3.1‐V5/His via the HindIII / BstXI sites to generate pcDNA3.1 mCD4‐V5/His. pcDNA4 ORF36‐myc/His was previously described (Bussey et al , ) and codes for ORF36 of Kaposi's sarcoma‐associated herpesvirus (KSHV). pPolI A/California/04/2009 NS was kindly provided by Toru Takimoto (University of Rochester Medical Center, USA) and subcloned into pcDNA3.1(‐) via the NotI / EcoRI sites to generate pcDNA3.1(‐) Cal NS1. pEFBOS mCherry‐mSTING (designated Cherry‐STING) expressing monomeric Cherry fused to the N terminus of murine STING and pIRESneo3 cGAS‐GFP (GFP fused to the C terminus of human cGAS) were kindly provided by Andrea Ablasser (Global Health Institute, Ecole Polytechnique Fédérale de Lausanne, Switzerland). pcDNA3 hSTING coding for untagged human STING was described previously (Christensen et al , ). pRL‐TK, which expresses Renilla luciferase under control of the thymidine kinase promoter, and pIRES2‐GFP were purchased from Promega and Clontech, respectively. pNF‐κB Luc, containing five NF‐κB responsive elements (TGGGGACTTTCCGC) upstream of the firefly luciferase gene, is commercially available from Agilent Technologies. pGL3basic IFNβ‐Luc (IFNβ‐Luc) and pGL3basic ISG56‐Luc (ISG56‐Luc) were described previously (Chan et al , ). ..

    Plasmid Preparation:

    Article Title: Modular Extracellular Sensor Architecture for Engineering Mammalian Cell-based Devices
    Article Snippet: .. Source plasmids for MESA components included pCL-CTIG (Addgene plasmid 14901), pRK1043 (Addgene plasmid 8835), pBI-MCS-EGFP (Addgene plasmid 16542), pBS mCD4 (Addgene plasmid 14613), AAV-FLEX-rev-ChR2-tdtomato (Addgene plasmid 18917), pEBFP2-Nuc (Addgene plasmid 14893), YFP-FKBP (Addgene plasmid 20175) and YFP-tagged FRB (YR) (Addgene plasmid 20148), pmCherry-C1 (Clontech 632524). ..

    Bioprocessing:

    Article Title: Modular Extracellular Sensor Architecture for Engineering Mammalian Cell-based Devices
    Article Snippet: .. Source plasmids for MESA components included pCL-CTIG (Addgene plasmid 14901), pRK1043 (Addgene plasmid 8835), pBI-MCS-EGFP (Addgene plasmid 16542), pBS mCD4 (Addgene plasmid 14613), AAV-FLEX-rev-ChR2-tdtomato (Addgene plasmid 18917), pEBFP2-Nuc (Addgene plasmid 14893), YFP-FKBP (Addgene plasmid 20175) and YFP-tagged FRB (YR) (Addgene plasmid 20148), pmCherry-C1 (Clontech 632524). ..



    Similar Products

    90
    Addgene inc pbluescript
    Pbluescript, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pbs+mcd4/pBS+mCD4+(Plasmid+%2314613)/pm38876098-660-12-13
    Average 90 stars, based on 1 article reviews
    pbluescript - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Addgene inc n a pbluescript mcd4 plasmid addgene
    N A Pbluescript Mcd4 Plasmid Addgene, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pbs+mcd4/pBS+mCD4+(Plasmid+%2314613)/pm38876098-565-164-168
    Average 90 stars, based on 1 article reviews
    n a pbluescript mcd4 plasmid addgene - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Addgene inc mcd4 cassette
    Mcd4 Cassette, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pbs+mcd4/pBS+mCD4+(Plasmid+%2314613)/pm38876098-660-8-13
    Average 90 stars, based on 1 article reviews
    mcd4 cassette - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Addgene inc pbs mcd4
    Pbs Mcd4, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pbs+mcd4/pBS+mCD4+(Plasmid+%2314613)/pmc06396373-273-21-25
    Average 90 stars, based on 1 article reviews
    pbs mcd4 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Addgene inc pbs mcd4 plasmid
    Pbs Mcd4 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pbs+mcd4/pBS+mCD4+(Plasmid+%2314613)/10__5114_slash_ceji__2018__80057-25-19-22
    Average 90 stars, based on 1 article reviews
    pbs mcd4 plasmid - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Addgene inc mouse cd4
    FIG. 1. The epitope of ibalizumab is likely to be conformational. (A) Binding of ibalizumab to soluble hCD4, <t>CD4-IgG2,</t> PR14 (aa 121 to 134), or TG26 (aa 115 to 140) as measured by ELISA. (B) Com- petition for ibalizumab binding to sCD4 in solution by CD4-IgG2 or PR14 as measured by ELISA. (C) Binding titers of mouse anti-PR14 antiserum to hCD4 or PR14. (D) FACS analysis of cell surface staining by ibalizumab in control 293T cells or cells transfected with hD2- <t>mCD4</t> or hCD4 plasmid DNA.
    Mouse Cd4, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pbs+mcd4/pBS+mCD4+(Plasmid+%2314613)/10__1128_slash_jvi__00453___10-67-0-11
    Average 90 stars, based on 1 article reviews
    mouse cd4 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    FIG. 1. The epitope of ibalizumab is likely to be conformational. (A) Binding of ibalizumab to soluble hCD4, CD4-IgG2, PR14 (aa 121 to 134), or TG26 (aa 115 to 140) as measured by ELISA. (B) Com- petition for ibalizumab binding to sCD4 in solution by CD4-IgG2 or PR14 as measured by ELISA. (C) Binding titers of mouse anti-PR14 antiserum to hCD4 or PR14. (D) FACS analysis of cell surface staining by ibalizumab in control 293T cells or cells transfected with hD2- mCD4 or hCD4 plasmid DNA.

    Journal: Journal of Virology

    Article Title: Epitope Mapping of Ibalizumab, a Humanized Anti-CD4 Monoclonal Antibody with Anti-HIV-1 Activity in Infected Patients

    doi: 10.1128/jvi.00453-10

    Figure Lengend Snippet: FIG. 1. The epitope of ibalizumab is likely to be conformational. (A) Binding of ibalizumab to soluble hCD4, CD4-IgG2, PR14 (aa 121 to 134), or TG26 (aa 115 to 140) as measured by ELISA. (B) Com- petition for ibalizumab binding to sCD4 in solution by CD4-IgG2 or PR14 as measured by ELISA. (C) Binding titers of mouse anti-PR14 antiserum to hCD4 or PR14. (D) FACS analysis of cell surface staining by ibalizumab in control 293T cells or cells transfected with hD2- mCD4 or hCD4 plasmid DNA.

    Article Snippet: Mouse CD4 (mCD4)/pVax was constructed by PCR amplification of pBS mCD4 (Addgene, Cambridge, MA) using primers 5 -CCC CCGAATTCCACCATGTGCCGAGCCATCTCTCTT-3 and 5 -CCCCCCTC GAGTCAGATGAGATTATGGCTCTT-3 , which contain the EcoRI and XhoI restriction sites.

    Techniques: Binding Assay, Enzyme-linked Immunosorbent Assay, Staining, Control, Transfection, Plasmid Preparation

    FIG. 2. Map of the ibalizumab epitope obtained by constructing and testing mouse-human chimeric CD4 molecules in binding studies using FACS. Sequence identity between mouse and human CD4 is denoted by an asterisk above the amino acid alignment. The -strands defined by Ryu et al. (24) are shown below the sequence alignment.

    Journal: Journal of Virology

    Article Title: Epitope Mapping of Ibalizumab, a Humanized Anti-CD4 Monoclonal Antibody with Anti-HIV-1 Activity in Infected Patients

    doi: 10.1128/jvi.00453-10

    Figure Lengend Snippet: FIG. 2. Map of the ibalizumab epitope obtained by constructing and testing mouse-human chimeric CD4 molecules in binding studies using FACS. Sequence identity between mouse and human CD4 is denoted by an asterisk above the amino acid alignment. The -strands defined by Ryu et al. (24) are shown below the sequence alignment.

    Article Snippet: Mouse CD4 (mCD4)/pVax was constructed by PCR amplification of pBS mCD4 (Addgene, Cambridge, MA) using primers 5 -CCC CCGAATTCCACCATGTGCCGAGCCATCTCTCTT-3 and 5 -CCCCCCTC GAGTCAGATGAGATTATGGCTCTT-3 , which contain the EcoRI and XhoI restriction sites.

    Techniques: Binding Assay, Sequencing

    FIG. 3. Results of fine-mapping the ibalizumab epitope by point mutations in the chimeric mCD4-hGACFG (A) or hCD4 (B). Amino acids in regions of interest for ibalizumab binding were mutated to alanine, glycine, or the corresponding mouse amino acid as shown by single-letter amino acid symbols above the CD4 sequence alignment. Mutations with no impact on CD4 expression or ibalizumab binding are unmarked. Residues critical to ibalizumab binding are enclosed by boxes. A gray dot denotes the amino acid that partially affected ibali- zumab binding. The asterisks indicate mutations that resulted in a substantial reduction (to 25%) in CD4 expression.

    Journal: Journal of Virology

    Article Title: Epitope Mapping of Ibalizumab, a Humanized Anti-CD4 Monoclonal Antibody with Anti-HIV-1 Activity in Infected Patients

    doi: 10.1128/jvi.00453-10

    Figure Lengend Snippet: FIG. 3. Results of fine-mapping the ibalizumab epitope by point mutations in the chimeric mCD4-hGACFG (A) or hCD4 (B). Amino acids in regions of interest for ibalizumab binding were mutated to alanine, glycine, or the corresponding mouse amino acid as shown by single-letter amino acid symbols above the CD4 sequence alignment. Mutations with no impact on CD4 expression or ibalizumab binding are unmarked. Residues critical to ibalizumab binding are enclosed by boxes. A gray dot denotes the amino acid that partially affected ibali- zumab binding. The asterisks indicate mutations that resulted in a substantial reduction (to 25%) in CD4 expression.

    Article Snippet: Mouse CD4 (mCD4)/pVax was constructed by PCR amplification of pBS mCD4 (Addgene, Cambridge, MA) using primers 5 -CCC CCGAATTCCACCATGTGCCGAGCCATCTCTCTT-3 and 5 -CCCCCCTC GAGTCAGATGAGATTATGGCTCTT-3 , which contain the EcoRI and XhoI restriction sites.

    Techniques: Binding Assay, Sequencing, Expressing

    FIG. 4. Localization of ibalizumab and M-T441 epitopes on three- dimensional structures of hCD4. The epitopes of ibalizumab (pink) and M-T441 (yellow) are highlighted on CD4 (blue) complexed to the core of gp120 (brown), with two views of the structure rotated 90° around a central vertical axis (A), or space-filling model of three CD4s (blue) bound to the trimer of gp120 core (brown), before and after a conformational rearrangement (B), as derived from the cryo-electron microscopy study of Liu et al. (17). The red dot in D1 denotes F43, a critical component that binds HIV-1 Env. The parts in green highlight the V5 loop in gp120.

    Journal: Journal of Virology

    Article Title: Epitope Mapping of Ibalizumab, a Humanized Anti-CD4 Monoclonal Antibody with Anti-HIV-1 Activity in Infected Patients

    doi: 10.1128/jvi.00453-10

    Figure Lengend Snippet: FIG. 4. Localization of ibalizumab and M-T441 epitopes on three- dimensional structures of hCD4. The epitopes of ibalizumab (pink) and M-T441 (yellow) are highlighted on CD4 (blue) complexed to the core of gp120 (brown), with two views of the structure rotated 90° around a central vertical axis (A), or space-filling model of three CD4s (blue) bound to the trimer of gp120 core (brown), before and after a conformational rearrangement (B), as derived from the cryo-electron microscopy study of Liu et al. (17). The red dot in D1 denotes F43, a critical component that binds HIV-1 Env. The parts in green highlight the V5 loop in gp120.

    Article Snippet: Mouse CD4 (mCD4)/pVax was constructed by PCR amplification of pBS mCD4 (Addgene, Cambridge, MA) using primers 5 -CCC CCGAATTCCACCATGTGCCGAGCCATCTCTCTT-3 and 5 -CCCCCCTC GAGTCAGATGAGATTATGGCTCTT-3 , which contain the EcoRI and XhoI restriction sites.

    Techniques: Derivative Assay, Cryo-Electron Microscopy

    FIG. 6. Results of fine-mapping of the M-T441 epitope by point muta- tions in the backbone of hD2-mCD4 (A) or hCD4 (B). Unmarked mutations have no impact on CD4 expression or M-T441 binding. Mutations enclosed by boxes substantially decreased M-T441 binding.

    Journal: Journal of Virology

    Article Title: Epitope Mapping of Ibalizumab, a Humanized Anti-CD4 Monoclonal Antibody with Anti-HIV-1 Activity in Infected Patients

    doi: 10.1128/jvi.00453-10

    Figure Lengend Snippet: FIG. 6. Results of fine-mapping of the M-T441 epitope by point muta- tions in the backbone of hD2-mCD4 (A) or hCD4 (B). Unmarked mutations have no impact on CD4 expression or M-T441 binding. Mutations enclosed by boxes substantially decreased M-T441 binding.

    Article Snippet: Mouse CD4 (mCD4)/pVax was constructed by PCR amplification of pBS mCD4 (Addgene, Cambridge, MA) using primers 5 -CCC CCGAATTCCACCATGTGCCGAGCCATCTCTCTT-3 and 5 -CCCCCCTC GAGTCAGATGAGATTATGGCTCTT-3 , which contain the EcoRI and XhoI restriction sites.

    Techniques: Expressing, Binding Assay